Drug profile

The FDA adverse-event record for Sulfa Drug (Unknown)

10 FDA reports name Sulfa Drug (Unknown), a lower-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#2648 of 2,679
by report volume (all drugs)
10
adverse-event reports
60.0%
death-coded share
Turkey
most-reported species

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Sulfa Drug (Unknown) ranks #2536 of 2679 by total reports (10). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1)
97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1)
#2536
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Signature read: Sulfa Drug (Unknown)'s 60.0% death-coded share is among the highest in the openFDA drug corpus.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
6
Deaths Reported
60.0%
Death-coded share of reports

Active Ingredients

Sulfa Drug (Unknown)

Administration Routes

UnknownOral

Species Affected

Turkey 5
Cattle 3
Cat 1
Human 1

Most Affected Breeds

Turkey (unknown) 5
Aberdeen Angus 1
Cattle (unknown) 1
Domestic Shorthair 1
Unknown 1
Mixed (Cattle) 1

Most Reported Reactions

Death 6
Lethargy (see also Central nervous system depression in Neurological) 2
Lateral recumbency 2
Musculoskeletal disorder NOS 1
Recumbency 1
Collapse (see also 'Cardio-vascular' and 'Systemic disorders') 1
Anaphylaxis 1
Abnormal movement NOS 1
Application site hair loss 1
Application site reddening 1
Application site skin change NOS 1
Dehydration 1

Outcome Breakdown

Died
6 (46.2%)
Outcome Unknown
3 (23.1%)
Ongoing
3 (23.1%)
Recovered/Normal
1 (7.7%)

Sulfa Drug (Unknown): high death-coded share in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Sulfa Drug (Unknown) (#2648 of 2,679 by report volume); death-coded 60.0%. PlainBreed drug row · death-coded share stamp 60.0% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →